5LBW
Structure of the human quinone reductase 2 (NQO2) in complex with volitinib
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06DA |
Synchrotron site | SLS |
Beamline | X06DA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2015-11-30 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.979 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 57.398, 81.372, 106.403 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 44.500 - 1.900 |
R-factor | 0.25404 |
Rwork | 0.253 |
R-free | 0.27050 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 5lbu |
RMSD bond length | 0.008 |
RMSD bond angle | 1.317 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | REFMAC |
Refinement software | REFMAC (5.8.0151) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.500 | 1.970 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.110 | 0.970 |
Number of reflections | 36213 | |
<I/σ(I)> | 7.49 | 1.3 |
Completeness [%] | 90.0 | 93 |
Redundancy | 4.7 | 4 |
CC(1/2) | 0.996 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | 200 mM sodium sulphate, 2.2 M ammonium sulphate |